On the Radar News
Most Popular On the Radar Story
Five biotech companies to watch
by Dr. Simos Simeonidis Poniard Pharmaceuticals (PARD Market Outperform) is expected to announce data from the Phase III SPEAR trial of picoplatin, its novel platinum compound for the treatment of Read more...
Latest Headlines
- November 18, 2009
- October 14, 2009
- September 1, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
